Evidence map›Paper›PMID 26892725›Full record

ArticleScientific reports2016

Risk Prediction Modeling of Sequencing Data Using a Forward Random Field Method.

Yalu Wen, Zihuai He, Ming Li, Qing Lu

Abstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yalu WenDepartment of Statistics, University of Auckland, Auckland 1010, New Zealand.
Zihuai HeDepartment of Biostatistics, University of Michigan, Ann Arbor, Michigan 48109, U.S.A.
Ming LiDepartment of Epidemiology and Biostatistics, Indiana University at Bloomington, Bloomington, IN 47405, U.S.A.
Qing LuDepartment of Epidemiology and Biostatistics, Michigan State University, East Lansing, MI 48824, U.S.A.

Funding

UT Southwestern Center for Translational Medicine (UL1/KL2/TL1)UL1TR001105 · NCATS · UT SOUTHWESTERN MEDICAL CENTER · PI TOTO, ROBERT DANIEL · 2013 to 2017
$24.5M
Indiana Clinical and Translational Sciences InstituteUL1TR001108 · NCATS · INDIANA UNIVERSITY INDIANAPOLIS · PI DENNE, SCOTT C., SHEKHAR, ANANTHA · 2013 to 2017
$23.3M
Gene-Gene/Gene-Environment Interactions Associated with Nicotine DependenceK01DA033346 · NIDA · MICHIGAN STATE UNIVERSITY · PI LU, QING · 2013 to 2017
$833k
High-dimensional Statistical Genetic Approach for Family-based Orofacial CleftsR03DE022379 · NIDCR · MICHIGAN STATE UNIVERSITY · PI LU, QING · 2012 to 2013
$441k
NCATS NIH HHS UL1 TR001105NCATS NIH HHS UL1 TR001108NIDA NIH HHS K01 DA033346NIDA NIH HHS K01DA033346NIDCR NIH HHS R03 DE022379NIDCR NIH HHS R03DE022379
6 · The paper itself

Abstract

With the advance in high-throughput sequencing technology, it is feasible to investigate the role of common and rare variants in disease risk prediction. While the new technology holds great promise to improve disease prediction, the massive amount of data and low frequency of rare variants pose great analytical challenges on risk prediction modeling. In this paper, we develop a forward random field method (FRF) for risk prediction modeling using sequencing data. In FRF, subjects' phenotypes are treated as stochastic realizations of a random field on a genetic space formed by subjects' genotypes, and an individual's phenotype can be predicted by adjacent subjects with similar genotypes. The FRF method allows for multiple similarity measures and candidate genes in the model, and adaptively chooses the optimal similarity measure and disease-associated genes to reflect the underlying disease model. It also avoids the specification of the threshold of rare variants and allows for different directions and magnitudes of genetic effects. Through simulations, we demonstrate the FRF method attains higher or comparable accuracy over commonly used support vector machine based methods under various disease models. We further illustrate the FRF method with an application to the sequencing data obtained from the Dallas Heart Study.

Indexed as

Genetic Association StudiesGenetic Predisposition to DiseaseModels, GeneticAlgorithmsComputer SimulationHigh-Throughput Nucleotide SequencingHumansPolymorphism, Single NucleotideReproducibility of ResultsRisk AssessmentROC CurveSupport Vector Machine

Identifiers

PMID26892725
PMCPMC4759688

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.